Lv6
2630 积分 2022-07-08 加入
Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotype
5天前
已完结
Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location
5天前
已完结
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer
6天前
已完结
Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study
7天前
已完结
Combinatorial Inhibition of Complement Factor D and BCL2 for Early-Onset Colorectal Cancer
7天前
已完结
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy
18天前
已完结
Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation
18天前
已完结
Relationship between progression‐free survival and overall survival in patients with advanced non‐small cell lung cancer treated with anticancer agents after first‐line treatment failure
3个月前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
3个月前
已完结
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)
3个月前
已完结
皖公网安备34019202002308
